Senior Scientist, Translational Immunology
$140K - $155K *
The Senior Scientist in Translational Immunology will support the expanding portfolio of small molecules targeting autoimmune diseases by designing and executing exploratory translational studies. Thi...
1 week ago
$110K - $130K *
Vividion Therapeutics is seeking an experienced Accounting Manager to oversee financial operations within a high-growth biotechnology company. The role involves managing the general ledger, financial...
1 week ago
Scientist II / Senior Scientist, Immunology
$130K - $145K *
Vividion is seeking a motivated Scientist II / Senior Scientist to join their Immunology team, focusing on small molecules targeting autoimmune diseases. The role involves designing and executing in v...
3 weeks ago
Project and Regulatory Toxicologist (Associate Director to Senior Director)
$180K - $260K *
The Project and Regulatory Toxicologist will leverage their expertise to guide safety assessments and interpret studies for small molecules in drug development. This role involves collaboration with m...
1 month ago
$220K - $260K *
The Director, Clinical Science will lead the design and execution of clinical studies, ensuring scientific rigor and collaboration with various stakeholders. This role involves developing trial protoc...
Director / Senior Director, Clinical Pharmacology - Oncology/Pharmacology
$150K - $250K *
The Director/Senior Director of Clinical Pharmacology will lead oncology and immunology drug development programs at Vividion, providing strategic and scientific expertise. This role involves designin...
Director / Senior Director, CMC Preformulation Sciences
$220K - $260K *
The Director/Senior Director of CMC Preformulation Sciences will lead preclinical formulation strategies to ensure the successful translation of discovery compounds into clinical candidates. This role...
$120K - $180K *
The DMPK Project Representative will lead and manage drug metabolism and pharmacokinetics studies to support preclinical and clinical development of the company's drug portfolio...